Lymphedema Completed Phase 2 Trials for Pazopanib (DB06589)

Also known as: Lymohedema / Lymphoedema / Lymphoedemas / Lymphoedema NOS

IndicationStatusPhase
DBCOND0029071 (Lymphedema)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00827372A Study of Vascular Endothelial Growth Factor (VEGF) Inhibition in Patients With Unilateral Upper Extremity Lymphedema Following Treatment for CancerSupportive Care